Filing Flows › Milestone Scientific (MLSS) › Q1 2026 › vs Q4 2025
Milestone Scientific (MLSS) Q1 2026 vs Q4 2025 (quarter over quarter)
Milestone Scientific's revenue rose $104K (+5%) from $2.1M in Q4 2025 to $2.2M in Q1 2026.
Milestone Scientific, Q1 2026: revenue $2.2M (-3% year over year), operating margin -38.3%, net loss $840K, operating cash flow $87K. The chart draws each line against Q4 2025, the increases inside each band.
Margins
| Q1 2026 | Q4 2025 | Change | |
|---|---|---|---|
| Free cash flow margin | 3.9% | -11.1% | +15.1 pts |
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $2.2M | $2.1M | $104K | +5% |
| Net loss | $840K | $1.1M | −$251K | -23% |
| Costs & expenses | $3.0M | $3.1M | −$147K | -5% |
| Operating costs | $3.0M | $3.1M | −$148K | -5% |
| Interest & other, net | $12K | $11K | $1K | +8% |
| Cost of revenue | $598K | $556K | $42K | +7% |
| SG&A | $2.4M | $2.5M | −$177K | -7% |
| Other operating costs | $19K | $19K | $299 | +2% |
| Operating cash sources | $927K | $864K | $62K | +7% |
| Depreciation & amortization | $19K | $19K | $299 | +2% |
| Share-based compensation | $257K | $99K | $158K | +159% |
| Working capital & other | $651K | $746K | −$96K | -13% |
| Net loss absorbed | $840K | $1.1M | −$251K | -23% |
| Operating cash flow | $87K | −$226K | $313K | — |
| Free cash flow (OCF − capex) | $85K | −$229K | $314K | — |
| Capital expenditures | $2K | $3K | −$1K | -48% |
Questions
How much did Milestone Scientific's revenue grow quarter over quarter in Q1 2026?
Milestone Scientific's revenue rose $104K (+5%) from $2.1M in Q4 2025 to $2.2M in Q1 2026.